Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Hepatic Safety of Currently Used Antiretroviral Regimens in HIV-infected Patients With Chronic Hepatitis B and/or Hepatitis C Under Real Life Conditions: The HEPAVIR HEPATIC SAFETY Cohort.
Sponsor: Complejo Hospitalario de Especialidades Juan Ramón Jimenez
This observational or N/A phase trial investigates Hepatitis B, Chronic and Hepatitis C, Chronic and is currently completed. Complejo Hospitalario de Especialidades Juan Ramón Jimenez leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Complejo Hospitalario de Especialidades Juan Ramón Jimenez
- Hospital Poniente
- Hospital Torrecárdenas
- Hospital Universitario Reina Sofia de Cordoba
- Hospital Universitario Virgen Macarena
- Hospital Universitario Virgen de la Victoria
- Hospital de la Línea de la Concepción
- Valme University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .